Oleksi Petrenko

ORCID: 0000-0002-9121-8843
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer-related Molecular Pathways
  • Mitochondrial Function and Pathology
  • Pancreatic and Hepatic Oncology Research
  • Cancer Cells and Metastasis
  • Epigenetics and DNA Methylation
  • TGF-β signaling in diseases
  • Nuclear Receptors and Signaling
  • Macrophage Migration Inhibitory Factor
  • Cell death mechanisms and regulation
  • Cancer Research and Treatments
  • Pluripotent Stem Cells Research
  • Phagocytosis and Immune Regulation
  • RNA modifications and cancer
  • Pancreatic function and diabetes
  • Cytokine Signaling Pathways and Interactions
  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Ubiquitin and proteasome pathways
  • interferon and immune responses
  • Microtubule and mitosis dynamics
  • CRISPR and Genetic Engineering
  • NF-κB Signaling Pathways
  • Signaling Pathways in Disease
  • PI3K/AKT/mTOR signaling in cancer
  • Renal and related cancers

Weatherford College
2025

Stony Brook University
2012-2024

State University of New York
1995-2009

Case Western Reserve University
2003

Ludwig-Maximilians-Universität München
2003

Princeton University
1999-2002

Institute of Molecular Biology and Genetics
1993

p53 promotes apoptosis in response to death stimuli by transactivation of target genes and transcription-independent mechanisms. We recently showed that wild-type rapidly translocates mitochondria multiple cultured cells. Mitochondrial physically interacts with antiapoptotic Bcl proteins, induces Bak oligomerization, permeabilizes mitochondrial membranes, cytochrome c release. Here we characterize the vivo. Mice were subjected γ irradiation or intravenous etoposide administration, followed...

10.1128/mcb.24.15.6728-6741.2004 article EN Molecular and Cellular Biology 2004-07-14

Immune evasion is a hallmark of KRAS-driven cancers, but the underlying causes remain unresolved. Here, we use mouse model pancreatic ductal adenocarcinoma to inactivate KRAS by CRISPR-mediated genome editing. We demonstrate that at an advanced tumor stage, dependence on for growth reduced and manifested in suppression antitumor immunity. KRAS-deficient cells retain ability form tumors immunodeficient mice. However, they fail evade host immune system syngeneic wild-type mice, triggering...

10.1038/s41467-021-21736-w article EN cc-by Nature Communications 2021-03-05

Macrophage migration inhibitory factor (MIF) is a mediator of host immunity and functions as high, upstream activator cells within the innate adaptive immunological systems. Recent studies have suggested potentially broader role for MIF in growth regulation because its ability to antagonize p53-mediated gene activation apoptosis. To better understand MIF's activity control, we generated characterized strain MIF-knockout (MIF-KO) mice inbred, C57BL/6 background. Embryonic fibroblasts from...

10.1073/pnas.1533295100 article EN Proceedings of the National Academy of Sciences 2003-07-23

A cDNA library enriched with Myc-responsive cDNAs but depleted of myc was used in a functional screen for growth enhancement c-myc-null cells. clone mitochondrial serine hydroxymethyltransferase (mSHMT) that capable partial complementation the defects cells identified. Expression analysis and chromatin immunoprecipitation demonstrated mSHMT is direct Myc target gene. Furthermore, separate gene encoding cytoplasmic isoform same enzyme also regulation. SHMT enzymes are major source one-carbon...

10.1128/mcb.22.16.5793-5800.2002 article EN Molecular and Cellular Biology 2002-07-28

Genetically or epigenetically defined reprogramming is a hallmark of cancer cells. However, causal association between genome and has not yet been conclusively established. In particular, little known about the mechanisms that underlie metastasis cancer, even less identity metastasizing this study, we used model conditional expression oncogenic KrasG12D allele in primary mouse cells to show dedifferentiation fundamental early step malignant transformation initiation. Our data indicate stable...

10.1073/pnas.1219592110 article EN Proceedings of the National Academy of Sciences 2013-02-19

The presence of tumor-infiltrating T cells is associated with favorable patient outcomes, yet most pancreatic cancers are immunologically silent and resistant to currently available immunotherapies. Here we show using a syngeneic orthotopic implantation model cancer that Pik3ca regulates tumor immunogenicity. Genetic silencing in KrasG12D/Trp53R172H-driven tumors resulted infiltration cells, complete regression, 100% survival immunocompetent host mice. By contrast, Pik3ca-null implanted...

10.1172/jci123540 article EN cc-by Journal of Clinical Investigation 2019-05-21

A dichotomy exists regarding the role of signal transducer and activator transcription 3 (STAT3) in cancer. Functional genetic studies demonstrate either an intrinsic requirement for STAT3 or a suppressive effect on common types These contrasting actions imply context dependency. To examine mechanisms that underlie function cancer, we evaluated impact activity KRAS-driven lung pancreatic Our study defines fundamental previously unrecognized maintenance epithelial cell identity...

10.1101/gad.311852.118 article EN Genes & Development 2018-08-22

TP73, despite significant homology to TP53, is not a classic tumor suppressor gene, since it exhibits upregulation of nonmutated products in human tumors and lacks phenotype p73-deficient mice. We recently reported that an N-terminally truncated isoform, DeltaNp73, upregulated breast gynecological cancers. further showed DeltaNp73 potent transdominant inhibitor wild-type p53 TAp73 cultured cells by efficiently counteracting their target gene transactivations, apoptosis, growth suppression...

10.1128/mcb.23.16.5540-5555.2003 article EN Molecular and Cellular Biology 2003-07-31

Significance Pancreatic cancer is characterized by aggressive growth and a high propensity for metastatic spread. Despite growing understanding of the genetic causes pancreatic cancer, mechanism timing metastasis, main cause deaths in patients, remain relatively unexplored. In this study, we used experimental mouse models carcinogenesis to show that hyperactivation Ras/MAPK/ERK pathway stabilization MYC protein are two driving forces behind development cells with potential. Our results...

10.1073/pnas.1319911111 article EN Proceedings of the National Academy of Sciences 2014-02-18

10.1016/j.molcel.2004.11.052 article EN publisher-specific-oa Molecular Cell 2005-01-01

Abstract Complex proapoptotic functions are essential for the tumor suppressor activity of p53. We recently described a novel transcription-independent mechanism that involves rapid action p53 at mitochondria and executes shortest known circuitry death signaling. Here, we examine if this p53-dependent mitochondrial program could be exploited suppression in vivo. To test this, engage Eμ-Myc transgenic mice, well-established model lymphomagenesis. show exclusive delivery to outer membrane...

10.1158/0008-5472.can-05-1084 article EN Cancer Research 2005-11-01

Macrophage migration inhibitory factor (MIF) has been shown to functionally inactivate the p53 tumor suppressor and inhibit p53-responsive gene expression apoptosis. To better understand role of MIF in cell growth biology, we evaluated MIF-null embryonic fibroblasts with respect their immortalization transformation properties. Although minor deviations characteristics MIF−/−fibroblasts were observed under normal culture conditions, MIF-deficient cells growth-impaired following introduction...

10.1074/jbc.m211985200 article EN cc-by Journal of Biological Chemistry 2003-03-01

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive, metastatic disease with limited treatment options. Factors contributing to the predisposition and therapy resistance in pancreatic cancer are not well understood. Here, we used mouse model of KRAS-driven carcinogenesis define distinct subtypes PDAC metastasis: epithelial, mesenchymal quasi-mesenchymal. We examined pro-survival signals these cells therapeutic response differences between them. Our data indicate that initiation...

10.18632/oncotarget.4538 article EN Oncotarget 2015-06-19

Mice engineered to express c-Myc in B cells (Emu-myc mice) develop lethal lymphomas which the gene encoding p53 tumor suppressor is frequently mutated. Whether homolog p73 also functions as a vivo remains controversial. Here we have shown that loss does not substantially affect disease onset and mortality Emu-myc mice. However, it alter phenotype of disease. Specifically, decreased nodal increased widespread extranodal dissemination. We further found acted dominant during Emu-myc-driven cell...

10.1172/jci40331 article EN Journal of Clinical Investigation 2010-05-20

Oncogenic mutations in KRAS are among the most common cancer. Classical models suggest that loss of epithelial characteristics and acquisition mesenchymal traits associated with cancer aggressiveness therapy resistance. However, mechanistic link between these phenotypes mutant biology remains to be established. Here, we identify STAT3 as a genetic modifier TGF-beta-induced transition. Gene expression profiling pancreatic cells identifies more than 200 genes commonly regulated by oncogenic...

10.7554/elife.92559 article EN cc-by eLife 2024-01-30

Oncogenic mutations in KRAS are among the most common cancer. Classical models suggest that loss of epithelial characteristics and acquisition mesenchymal traits associated with cancer aggressiveness therapy resistance. However, mechanistic link between these phenotypes mutant biology remains to be established. Here, we identify STAT3 as a genetic modifier TGF-beta-induced transition. Gene expression profiling pancreatic cells identifies more than 200 genes commonly regulated by oncogenic...

10.7554/elife.92559.2 article EN cc-by eLife 2024-04-04

Macrophage migration inhibitory factor (MIF) is a ubiquitously expressed pro-inflammatory mediator that has also been implicated in the process of oncogenic transformation and tumor progression. We used genetic approach to show deletion MIF gene mice several major consequences for proliferative transforming properties cells. MIF-deficient cells exhibit increased resistance transformation. The defects associated with deficiency can be overcome through concomitant inactivation p53 Rb/E2F...

10.1186/1747-1028-2-22 article EN cc-by Cell Division 2007-01-01
Coming Soon ...